Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ

被引：0
作者：
Shu-Chuan Chang
Sheng-Shun Yang
Chiu-Chun Chang
Chun-Che Lin
Yueh-Chin Chung
Tsai-Chung Li
机构：
[1] Central Taiwan University of Science and Technology,Department of Nursing
[2] China Medical University,Department of Public Health
[3] Taichung Veterans General Hospital,Division of Gastroenterology & Hepatology, Department of Internal Medicine
[4] National Yang-Ming Medical University,School of Medicine
[5] Chung Shan Medical University,Institute of Medicine
[6] Chung Shan Medical University Hospital,Division of Gastroenterology & Hepatology
[7] China Medical University,Graduate Institute of Biostatistics, College of Management
[8] Asia University,Department of Healthcare Administration, College of Health Science
来源：
Health and Quality of Life Outcomes | / 12卷
关键词：
Chronic hepatitis C; Antiviral treatment; Health-related quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 235 条
[1]  
Chen C(2007)Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants J Formos Med Assoc 106 148-155
[2]  
Yang P(2002)Course and outcome of hepatitis C Hepatology 36 S21-S29
[3]  
Huang G(2010)Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection Clin Gastroenterol Hepatol 8 924-668
[4]  
Lee H(1996)Hepatitis C Ann Intern Med 125 658-982
[5]  
Sung J(2002)Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975-965
[6]  
Sheu J(2001)Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 958-S244
[7]  
Hoofnagle JH(2002)Side effects of therapy of hepatitis C and their management Hepatology 36 S237-1269
[8]  
Jacobson IM(2008)Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial Clin Infect Dis 47 1260-408
[9]  
Davis GL(2009)The lived experience of treatment for hepatitis C Gastroenterol Nurs 32 401-893
[10]  
El-Serag H(2011)Quality of life in patients with chronic hepatitis C after PEG-Interferon a-2a therapy Zhonghua Gan Zang Bing Za Zhi 19 890-524
12345678910